New Market Study: "Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market"
GBI Research's new report, "Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market", presents various tools and strategies which can accelerate a drug to the market. In this report, GBI Research has studied various hurdles at different stages of drug development that can halt a drug's development. The report provides detailed information about the need for accelerated drug development. Declining R&D productivity is highlighted as one of the major needs to...
View full press release